Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

84.86
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
69.53
Today|||52-Week Range
86.90
+16.50%
Year-to-Date
CAR T Stocks in Focus with ASH 2017 Meet: GILD, JUNO & More
Dec 15 / Zacks.com - Paid Partner Content
Novartis Announces Positive Data on Sickle Cell Disease Drug
Dec 12 / Zacks.com - Paid Partner Content
Cancer Space Update: Roche, Pfizer & Regeneron Make Data Presentations
Dec 15 / Zacks.com - Paid Partner Content
Gilead (GILD) Posts Updated Data on CAR-T Therapy Yescarta
Dec 11 / Zacks.com - Paid Partner Content
Roche/AbbVie Report Positive Phase III Results on Venclexta
Dec 13 / Zacks.com - Paid Partner Content
Novartis Reports Updated Results from Kymriah's JULIET Study
Dec 11 / Zacks.com - Paid Partner Content
Juno Reports Additional Data on CAR-T Therapy, Shares Drop
Dec 12 / Zacks.com - Paid Partner Content
Here's Why Bluebird Bio (BLUE) Stock Skyrocketed Today
Dec 11 / Zacks.com - Paid Partner Content
Regeneron's sBLA for Eylea Accepted by FDA, Action Date Set
Dec 12 / Zacks.com - Paid Partner Content
Incyte (INCY) Reports Phase III Follow-Up Data for Jakafi
Dec 11 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close84.86
Today’s open84.43
Day’s range84.30 - 84.95
Volume1,281,851
Average volume (3 months)1,681,316
Market cap$197.5B
Data as of 4:02pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)-61.91%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.26%
Revenue growth (last year)-1.90%
P/E ratio31.0
Price/Sales3.61
Price/Book2.67

Competitors

 Today’s
change
Today’s
% change
PFEPfizer0.000.00%
MRKMerck0.000.00%
SNYSanofi0.000.00%
ABBVAbbVie0.000.00%
Data as of 4:02pm ET, 12/15/2017

Financials

Next reporting dateJanuary 24, 2018
EPS forecast (this quarter)$1.20
Annual revenue (last year)$48.4B
Annual profit (last year)$6.7B
Net profit margin13.83%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Joseph Jimenez
Chief Financial Officer
Harry Kirsch
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts